Copyright © Inderes 2011 - present. All rights reserved.

Midsona

8.68

 

SEK

 

0 %

Less than 1K followers

MSON B

NASDAQ Stockholm

Food & Beverage

Consumer Goods & Services

0%
-1.59%
-2.03%
+9.87%
+1.52%
-5.55%
-64.86%
-82.46%
-63.86%

Midsona operates in the health and wellness industry and focuses on the manufacture and distribution of dietary supplements and health products. The company's products are aimed at individuals and retailers looking for healthy alternatives. The business is global with a primary presence in Europe. Midsona was founded in 1892 and is headquartered in the city of Malmö, Sweden.

Read more
Market cap
1.26B SEK
Turnover
137.48K SEK
Revenue
3.73B
EBIT %
3.43 %
P/E
26.3
Dividend yield-%
2.3 %
Financial calendar
17/7
2025

Interim report Q2'25

22/10
2025

Interim report Q3'25

30/1
2026

Annual report '25

ShowingAll content types
Third party research

Midsona: Feedback from ABGSC Investor Days - ABG

Well-positioned in a growing market Reducing SKU's and suppliers to improve profitability Expect market to re-enter its consolidation phase A growing market with high willingness to pay Today, we hosted Midsona's departing CEO Peter Åsberg at ABGSC's...

Midsona

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research

Midsona: Starting to invest more in its best brands - ABG

Limited estimate revisions We expect more solid growth from its own brands Trading at '25e EV/EBITA of ~10x Adj. EBIT slightly lower than expected on one-off cost Q1 was in line with our estimates for sales, but slightly below for EBIT. The EBIT miss...

Midsona
Third party research

Midsona: Decent operating delivery - ABG

Sales -1% and adj. EBIT -18% vs. ABGSCe Operating cash flow significantly better than expected Likely slightly negative consensus estimate revisions Q1'25 report The Q1 report was in line with expectations on sales, but a bit lower than expected on EBIT...

Midsona
Third party research

Midsona: Expect a year of continued improvement - ABG

Minor estimate changes Q1e: 2% organic growth and margin improvements Trading at NTM EV/EBITA of ~8x What to expect in Q1'25e We anticipate 2% y-o-y organic growth in Q1'25, implying sales of SEK 942m and EBIT of SEK 45m, for a margin of 4.8%. The organic...

Midsona
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.